Financials data is unavailable for this security.
View more
Income statement information is not available for Biostem Technologies Inc .
Gross margin | 94.84% |
---|---|
Net profit margin | 6.81% |
Operating margin | 9.75% |
Return on assets | 26.03% |
---|---|
Return on equity | 148.34% |
Return on investment | 135.75% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Biostem Technologies Inc fell by 532.73k. Cash Flow from Financing totalled 3.18m or 19.04% of revenues. In addition the company used 3.50m for operations while cash used for investing totalled 210.33k.
Cash flow per share | 0.731 |
---|---|
Price/Cash flow per share | 15.11 |
Book value per share | 1.40 |
---|---|
Tangible book value per share | 1.37 |
More ▼
Balance sheet in USDView more
Current ratio | 1.25 |
---|---|
Quick ratio | 1.23 |
Total debt/total equity | 0.1871 |
---|---|
Total debt/total capital | 0.1576 |
More ▼